Related Experiment Video
Updated: May 13, 2026
03:45
Investigating the Pathogenesis of MYH7 Mutation Gly823Glu in Familial Hypertrophic Cardiomyopathy using a Mouse Model
Published on: August 8, 2022
Diagnostic uncertainties and future perspectives in noncompaction cardiomyopathy
Osama Ii Soliman1, Marcel L Geleijnse, Kadir Caliskan
1Department of Cardiology , Thoraxcenter, Erasmus MC, Rotterdam , The Netherlands.
Expert Opinion on Medical Diagnostics
|March 14, 2013
Summary
Noncompaction cardiomyopathy (NCCM) diagnosis faces challenges due to its complex nature and limited research. Overcoming these requires standardized definitions and advanced imaging techniques for better understanding.
Area of Science:
- Cardiology
- Pathoanatomy
- Medical Imaging
Background:
- Noncompaction cardiomyopathy (NCCM) is a pathoanatomic entity with uncertain origins in embryonic development.
- Despite decades of research, diagnostic uncertainties and precise definitions persist for NCCM.
- This review addresses current challenges and proposes future directions for NCCM diagnosis.
Purpose of the Study:
- To review uncertainties in NCCM nomenclature, classification, pathophysiology, and diagnostic criteria.
- To contrast newer imaging modalities with conventional assessments.
- To outline future research directions for improved NCCM diagnosis.
Main Methods:
- Review of existing literature on NCCM nomenclature, classification, and pathophysiology.
- Comparison of conventional echocardiography with advanced imaging techniques (cardiac MRI, 3D echocardiography, deformation imaging).
- Analysis of limitations in current diagnostic criteria and study methodologies.
Main Results:
- NCCM understanding is limited by disease heterogeneity and phenotype-genotype overlap.
- Small sample sizes, selection bias, and retrospective designs hinder most NCCM studies.
- Current diagnostic criteria possess limitations requiring further refinement.
Conclusions:
- Integrated research in pathoanatomy, imaging, and genetics is crucial for NCCM.
- Collaborative international registries with nonselective populations are needed for better understanding and diagnosis.
- Establishing clear pathoanatomic definitions is essential for uniform imaging diagnosis of NCCM.
Related Concept Videos
01:25Cardiomyopathy I: Introduction and Classification
Cardiomyopathy, or CMP, is a group of diseases affecting the myocardial structure, impairing its ability to pump blood effectively. This condition can lead to arrhythmias, heart failure, or sudden cardiac death.Cardiomyopathies are classified into primary and secondary categories:Primary Cardiomyopathy refers to conditions involving only the heart muscle that are often idiopathic (of unknown cause) or genetic. They primarily affect the myocardium without the involvement of other systemic...
01:29Cardiomyopathy III: Hypertrophic Cardiomyopathy
Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
01:30Cardiomyopathy II: Dilated Cardiomyopathy
Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
01:29Cardiomyopathy IV: Restrictive Cardiomyopathy
Restrictive cardiomyopathy (RCM) is a rare heart muscle disease characterized by impaired ventricular filling due to stiffened ventricular walls, leading to significant diastolic dysfunction.EtiologyRestrictive cardiomyopathy can arise from both inherited and acquired diseases, many of which are systemic. It is categorized into four main types: infiltrative, storage, non-infiltrative, and endomyocardial diseases.Infiltrative diseases, such as amyloidosis, lead to RCM by depositing amyloid...
01:29Cardiomyopathy V: Interprofessional Care
Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...
01:29Cardiomyopathy VI: Nursing Management
Assessment: Nursing management of patients with cardiomyopathy begins with a thorough assessment of the patient's history, including a family history of cardiomyopathy or sudden cardiac death, personal history of heart disease, hypertension, diabetes, and any alcohol consumption or drug use.During the physical examination, assess vital signs, look for signs of heart failure (such as edema, jugular venous distention, and cyanosis), auscultate for abnormal heart sounds (like murmurs and gallops),...